Practical aspects of implementation of helical tomotherapy for intensity-modulated and image-guided radiotherapy

Clinical Oncology

Volumn 22, Issue 4, 2010, Pages 294-312

  Burnet, N G ^a   Adams, E J ^b   Fairfoul, J ^b   Tudor, G S J ^b   Hoole, A C F ^b   Routsis, D S ^b   Dean, J C ^b   Kirby, R D ^b   Cowen, M ^b   Russell, S G ^b   Rimmer, Y L ^b   Thomas, S J ^b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

Helical tomotherapy; Image guided intensity modulated radiotherapy

Indexed keywords

ANUS CANCER; ARTICLE; BLADDER CANCER; BREAST CANCER; COMPUTER ASSISTED RADIOTHERAPY; COMPUTER PROGRAM; CONTROLLED STUDY; DOSIMETRY; HEALTH CARE DELIVERY; HUMAN; IMAGE ANALYSIS; IMAGE PROCESSING; INGUINAL LYMPH NODE; INTENSITY MODULATED RADIATION THERAPY; LINEAR ACCELERATOR; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALIGNANT NEOPLASTIC DISEASE; PARAAORTIC LYMPH NODE; PATIENT POSITIONING; PATIENT SELECTION; PELVIS LYMPH NODE; PRESCRIPTION; PRIORITY JOURNAL; PROSTATE CANCER; QUALITY CONTROL; RADIATION DOSE; RADIATION DOSE FRACTIONATION; SARCOMA; SKULL BASE TUMOR; SPINE CANCER; STAFF TRAINING; TEAMWORK; THORAX CANCER; TOMOTHERAPY; TREATMENT PLANNING; UTERINE CERVIX CANCER;

FEMALE; GUIDELINE ADHERENCE; HUMANS; MALE; NEOPLASMS; QUALITY ASSURANCE, HEALTH CARE; RADIOLOGY DEPARTMENT, HOSPITAL; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, INTENSITY-MODULATED; TOMOGRAPHY, SPIRAL COMPUTED;

EID: 77951720308     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clon.2010.02.003     Document Type: Article

References (83)

1. Intensity-modulated radiotherapy: current status and issues of interest. Int J Radiat Oncol Biol Phys 2001, 51:880-914. Intensity Modulated Radiation Therapy Collaborative Working Group.
2. International Atomic Energy Agency (IAEA) Transition from 2-D radiotherapy to 3-D conformal and intensity modulated radiotherapy 2008, IAEA, Vienna.
3. Pow E.H., Kwong D.L., McMillan A.S., et al. Xerostomia and quality of life after intensity-modulated radiotherapy vs conventional radiotherapy for early-stage nasopharyngeal carcinoma: initial report on a randomized controlled clinical trial. Int J Radiat Oncol Biol Phys 2006, 66:981-991.
4. Xing L., Thorndyke B., Schreibmann E., et al. Overview of image-guided radiation therapy. Med Dosim 2006, 31(2):91-112.
5. Verellen D., Ridder M.D., Linthout N., Tournel K., Soete G., Storme G. Innovations in image-guided radiotherapy. Nat Rev Cancer 2007, 7(12):949-960.
6. Veldeman L., Madani I., Hulstaert F., De Meerleer G., Mareel M., De Neve W. Evidence behind use of intensity-modulated radiotherapy: a systematic review of comparative clinical studies. Lancet Oncol 2008, 9(4):367-375.
7. Donovan E., Bleakley N., Denholm E., et al. Randomised trial of standard 2D radiotherapy (RT) versus intensity modulated radiotherapy (IMRT) in patients prescribed breast radiotherapy. Radiother Oncol 2007, 82(3):254-264. Breast Technology Group.
8. Nutting C., A'Hern R., Rogers M.S., et al. First results of a phase III multicenter randomized controlled trial of intensity modulated (IMRT) versus conventional radiotherapy (RT) in head and neck cancer (PARSPORT: ISRCTN48243537; CRUK/03/005). J Clin Oncol 2009, 27. on behalf of the PARSPORT Trial Management Group, (Suppl):abstract LBA6006.
9. Mackie T.R., Olivera G.H., Kapatoes J.M., et al. Helical tomotherapy. Intensity-modulated radiation therapy: the state of the art 2003, 247-284. American Association of Physicists in Medicine, College Park, MD. P. Palta, T.R. Mackie (Eds.).
10. Mackie T.R. History of tomotherapy. Phys Med Biol 2006, 51(13):R427-453.
11. Welsh J.S., Patel R.R., Ritter M.A., Harari P.M., Mackie T.R., Mehta M.P. Helical tomotherapy: an innovative technology and approach to radiation therapy. Technol Cancer Res Treat 2002, 1(4):311-316.
12. Welsh J.S., Lock M., Harari P.M., et al. Clinical implementation of adaptive helical tomotherapy: a unique approach to image-guided intensity modulated radiotherapy. Technol Cancer Res Treat 2006, 5(5):465-479.
13. Yartsev S., Kron T., Van Dyk J. Tomotherapy as a tool in image-guided radiation therapy (IGRT): theoretical and technological aspects. Biomed Imaging Intervention J 2007, 3(1):e16.
14. IPEM Report no.96 Guidance for the clinical implementation of intensity modulated radiation therapy 2008, Institute of Physics and Engineering in Medicine (IPEM), London.
15. Whitton A., Warde P., Sharpe M., et al. Organisational standards for the delivery of intensity-modulated radiation therapy in Ontario. Clin Oncol (R Coll Radiol) 2009, 21(3):192-203.
16. HMSO The Ionising Radiation (Medical Exposures) Regulations 2000, as amended by the Ionising Radiation (Medical Exposures) (Amendments) Regulations 2006, SI 2006/2523. Available from: http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_4007957.
17. Mayles W.P.M., Lake R., McKenzie A., et al. Physics aspects of quality control in radiotherapy. IPEM Report no. 81 1999, Institute of Physics and Engineering in Medicine (IPEM), York.
18. Fenwick J.D., Tome W.A., Jaradat H.A., et al. Quality assurance of a helical tomotherapy machine. Phys Med Biol 2004, 49(13):2933-2953.
19. Balog J., Holmes T., Vaden R. Helical tomotherapy dynamic quality assurance. Med Phys 2006, 33:3939-3950.
20. Sarkar V., Lin L., Shi C., Papanikolaou N. Quality assurance of the multileaf collimator with helical tomotherapy: design and implementation. Med Phys 2007, 34(7):2949-2956.
21. Broggi S., Cattaneoa G.M., Molinellia S., et al. Results of a two-year quality control program for a helical tomotherapy unit. Radiother Oncol 2008, 86:231-241.
22. Gibbons J.P., Smith K., Cheek D., Rosen I. Independent calculation of dose from a helical TomoTherapy unit. J Appl Clin Med Phys 2009, 10(1):103-119.
23. Zhao Y.L., Mackenzie M., Kirkby C., Fallone B.G. Monte Carlo evaluation of a treatment planning system for helical tomotherapy in an anthropomorphic heterogeneous phantom and for clinical treatment plans. Med Phys 2008, 35(12):5366-5374.
24. Rimmer Y.L., Burnet N.G., Routsis D.S., et al. Practical issues in the implementation of image-guided radiotherapy for the treatment of prostate cancer within a UK department. Clin Oncol 2008, 20(1):22-30.
25. Dean JC, Routsis DS. Training Needs of Radiographers for Implementing TomoTherapy in NHS Practice. J Radiother Practice (in press).
26. Beavis A.W., Phillips R., Ward J.W. Radiotherapy training tools for yesterday's future. Imaging Oncol 2007, 30-35.
27. Rimmer YL. The implementation and optimisation of image-guided radiotherapy in prostate cancer. MD thesis, University of East Anglia, 2009.
28. de Crevoisier R., Tucker S.L., Dong L., et al. Increased risk of biochemical and local failure in patients with distended rectum on the planning CT for prostate cancer radiotherapy. Int J Radiat Oncol Biol Phys 2005, 62(4):965-973.
29. Ghilezan M., Yan D., Liang J., Jaffray D., Wong J., Martinez A. Online image-guided intensity-modulated radiotherapy for prostate cancer: how much improvement can we expect? a theoretical assessment of clinical benefits and potential dose escalation by improving precision and accuracy of radiation delivery. Int J Radiat Oncol Biol Phys 2004, 60(5):1602-1610.
30. Kupelian P.A., Langen K.M., Zeidan O.A., et al. Daily variations in delivered doses in patients treated with radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys 2006, 66(3):876-882.
31. Kupelian P.A., Willoughby T.R., Reddy C.A., Klein E.A., Mahadevan A. Impact of image guidance on outcomes after external beam radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys 2008, 70(4):1146-1150.
32. Cozzarini C., Fiorino C., Di Muzio N., et al. Significant reduction of acute toxicity following pelvic irradiation with helical tomotherapy in patients with localized prostate cancer. Radiother Oncol 2007, 84(2):164-170.
33. Zelefsky M.J., Levin E.J., Hunt M., et al. Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys 2008, 70(4):1124-1129.
34. Viani G.A., Stefano E.J., Afonso S.L. Higher-than-conventional radiation doses in localized prostate cancer treatment: a meta-analysis of randomized, controlled trials. Int J Radiat Oncol Biol Phys 2009, 74(5):1405-1418.
35. Cahlon O., Hunt M., Zelefsky M.J. Intensity-modulated radiation therapy: supportive data for prostate cancer. Semin Radiat Oncol 2008, 18(1):48-57.
36. Clark C.H., Bidmead A.M., Mubata C.D., Harrington K.J., Nutting C.M. Intensity-modulated radiotherapy improves target coverage, spinal cord sparing and allows dose escalation in patients with locally advanced cancer of the larynx. Radiother Oncol 2004, 70(2):189-198.
37. Sterzing F., Schubert K., Sroka-Perez G., Kalz J., Debus J., Herfarth K. Helical tomotherapy. Experiences of the first 150 patients in Heidelberg. Strahlenther Onkol 2008, 184(1):8-14.
38. Thomas S.J., Hoole A.C. The effect of optimization on surface dose in intensity modulated radiotherapy (IMRT). Phys Med Biol 2004, 49(21):4919-4928.
39. Thilmann C., Grosser K.H., Rhein B., Zabel A., Wannenmacher M., Debus J. Virtual bolus for inversion radiotherapy planning in intensity-modulated radiotherapy of breast carcinoma within the scope of adjuvant therapy. Strahlenther Onkol 2002, 178(3):139-146.
40. International Commission on Radiation Units and Measurements. Prescribing, recording and reporting photon beam therapy (supplement to ICRU Report 50). ICRU Report 62. Bethesda, MD, ICRU.
41. International Commission on Radiation Units and Measurements Prescribing, recording and reporting electron beam therapy. ICRU Report 71. J ICRU 2004, 4(1):25-37.
42. Nguyen T.B., Hoole A.C., Burnet N.G., Thomas S.J. Dose-volume population histogram: a new tool for evaluating plans whilst considering geometrical uncertainties. Phys Med Biol 2009, 54(4):935-947.
43. Kissick M.W., Fenwick J., James J.A., et al. The helical tomotherapy thread effect. Med Phys 2005, 32(5):1414-1423.
44. Thomas S.J. Capacity and demand models for radiotherapy treatment machines. Clin Oncol 2003, 15:353-358.
45. Hendry J.H., Bentzen S.M., Dale R.G., et al. A modelled comparison of the effects of using different ways to compensate for missed treatment days in radiotherapy. Clin Oncol (R Coll Radiol) 1996, 8(5):297-307.
46. Burnet N.G., Benson R.J., Williams M.V., Peacock J.H. Improving cancer outcomes through radiotherapy. Lack of UK radiotherapy resources prejudices cancer outcomes. Br Med J 2000, 320(7229):198-199.
47. Royal College of Radiologists The timely delivery of radical radiotherapy: standards and guidelines for the management of unscheduled treatment interruptions 2008, Royal College of Radiologists, London. 3rd ed.
48. Burnet N.G., Routsis D.S., Murrell P., et al. A tool to measure radiotherapy complexity and workload: derivation from the Basic Treatment Equivalent (BTE) concept. Clin Oncol 2001, 13:14-23.
49. Clark B., Montgomery L., Fox G., et al. Implementation and workflow for a clinical tomotherapy unit. Radiother Oncol 2006, 80(Suppl. 1):S55.
50. Bauman G., Yartsev S., Rodrigues G., et al. A prospective evaluation of helical tomotherapy. Int J Radiat Oncol Biol Phys 2007, 68(2):632-641.
51. Bijdekerke P., Verellen D., Tournel K., et al. TomoTherapy: implications on daily workload and scheduling patients. Radiother Oncol 2008, 86(2):224-230.
52. McNair H.A., Francis G., Balyckyi J. Clinical implementation of dynamic intensity-modulated radiotherapy: radiographers' perspectives. Br J Radiol 2004, 77(918):493-498.
53. Adams E.J., Convery D.J., Cosgrove V.P., et al. Clinical implementation of dynamic and step-and-shoot IMRT to treat prostate cancer with high risk of pelvic lymph node involvement. Radiother Oncol 2004, 70(1):1-10.
54. Houghton F., Benson R.J., Tudor G.S., et al. An assessment of action levels in imaging strategies in head and neck cancer using TomoTherapy. Are our margins adequate in the absence of image guidance?. Clin Oncol 2009, 21:720-727.
55. Royal College of Radiologists, Society and College of Radiographers, Institute of Physics and Engineering in Medicine On target: ensuring geometric accuracy in radiotherapy 2008, Royal College of Radiologists, London.
56. British Institute of Radiology Geometric uncertainties in radiotherapy - defining the planning target volume 2003, British Institute of Radiology, London.
57. Beldjoudi G., Yartsev S., Battista J.J., Van Dyk J. Optimisation du processus d'imagerie de haute énergie (MVCT) pour la tomothérapie hélicoïdale des cancers de la prostate. Cancer Radiother 2008, 12(5):316-322.
58. Den RB, Doemer A. Kubicek G, et al. Daily image guidance with cone-beam computed tomography for head-and-neck cancer intensity-modulated radiotherapy: a prospective study. Int J Radiat Oncol Biol Phys in press, doi:10.1016/j.ijrobp.2009.03.05g.
59. Zeidan O.A., Langen K.M., Meeks S.L., et al. Evaluation of image-guidance protocols in the treatment of head and neck cancers. Int J Radiat Oncol Biol Phys 2007, 67(3):670-677.
60. Li X.A., Qi X.S., Pitterle M., et al. Interfractional variations in patient setup and anatomic change assessed by daily computed tomography. Int J Radiat Oncol Biol Phys 2007, 68(2):581-591.
61. Kupelian P.A., Lee C., Langen K.M., et al. Evaluation of image-guidance strategies in the treatment of localized prostate cancer. Int J Radiat Oncol Biol Phys 2008, 70(4):1151-1157.
62. Forrest L.J., Mackie T.R., Ruchala K., et al. The utility of megavoltage computed tomography images from a helical tomotherapy system for setup verification purposes. Int J Radiat Oncol Biol Phys 2004, 60(5):1639-1644.
63. Song W.Y., Chiu B., Bauman G.S., et al. Prostate contouring uncertainty in megavoltage computed tomography images acquired with a helical tomotherapy unit during image-guided radiation therapy. Int J Radiat Oncol Biol Phys 2006, 65(2):595-607.
64. Mackie T.R., Kapatoes J., Ruchala K., et al. Image guidance for precise conformal radiotherapy. Int J Radiat Oncol Biol Phys 2003, 56(1):89-105.
65. Bortfeld T., Webb S. Single-Arc IMRT?. Phys Med Biol 2009, 54(1):N9-N20.
66. Sheng K., Molloy J.A., Read P.W. Intensity-modulated radiation therapy (IMRT) dosimetry of the head and neck: a comparison of treatment plans using linear accelerator-based IMRT and helical tomotherapy. Int J Radiat Oncol Biol Phys 2006, 65(3):917-923.
67. Chen A.M., Jennelle R.L., Sreeraman R., et al. Initial clinical experience with helical tomotherapy for head and neck cancer. Head Neck 2009, 31(12):1571-1578.
68. Kupelian P.A., Langen K.M., Willoughby T.R., Zeidan O.A., Meeks S.L. Image-guided radiotherapy for localized prostate cancer: treating a moving target. Semin Radiat Oncol 2008, 18(1):58-66.
69. Fiorino C., Dell'Oca I., Pierelli A., et al. Significant improvement in normal tissue sparing and target coverage for head and neck cancer by means of helical tomotherapy. Radiother Oncol 2006, 78(3):276-282.
70. Ahmed M., Hansen V.N., Harrington K.J., Nutting C.M. Reducing the risk of xerostomia and mandibular osteoradionecrosis: the potential benefits of intensity modulated radiotherapy in advanced oral cavity carcinoma. Med Dosim 2009, 34(3):217-224.
71. Galvin J.M., Ezzell G., Eisbrauch A., et al. Implementing IMRT in clinical practice: a joint document of the American Society for Therapeutic Radiology and Oncology and the American Association of Physicists in Medicine. Int J Radiat Oncol Biol Phys 2004, 58(5):1616-1634. American Society for Therapeutic Radiology and Oncology; American Association of Physicists in Medicine.
72. Barnett G.C., Wilkinson J., Moody A.M., et al. A randomised controlled trial of forward-planned radiotherapy (IMRT) for early breast cancer: baseline characteristics and dosimetry results. Radiother Oncol 2009, 92(1):34-41.
73. Mundt A.J., Mell L.K., Roeske J.C. Preliminary analysis of chronic gastrointestinal toxicity in gynecology patients treated with intensity-modulated whole pelvic radiation therapy. Int J Radiat Oncol Biol Phys 2003, 56(5):1354-1360.
74. Chao K.S., Majhail N., Huang C.J., et al. Intensity-modulated radiation therapy reduces late salivary toxicity without compromising tumor control in patients with oropharyngeal carcinoma: a comparison with conventional techniques. Radiother Oncol 2001, 61(3):275-280.
75. Duthoy W., Boterberg T., Claus F., et al. Postoperative intensity-modulated radiotherapy in sinonasal carcinoma: clinical results in 39 patients. Cancer 2005, 104(1):71-82.
76. Dearnaley D.P., Sydes M.R., Graham J.D., et al. Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: first results from the MRC RT01 randomised controlled trial. Lancet Oncol 2007, 8(6):475-487. RT01 collaborators.
77. Huang E., Teh B.S., Strother D.R., et al. Intensity-modulated radiation therapy for pediatric medulloblastoma: early report on the reduction of ototoxicity. Int J Radiat Oncol Biol Phys 2002, 52(3):599-605.
78. Dearnaley D.P., Khoo V.S., Norman A.R., et al. Comparison of radiation side-effects of conformal and conventional radiotherapy in prostate cancer: a randomised trial. Lancet 1999, 353(9149):267-272.
79. Ting J.Y., Scarbrough T.J. Intensity-modulated radiation therapy and image-guided radiation therapy: small clinic implementation. Hematol Oncol Clin North Am 2006, 20(1):63-86.
80. National Radiotherapy Advisory Group Report to Ministers Radiotherapy: developing a world class service for England Available from. http://www.cancerimprovement.nhs.uk/documents/radiotherapy/NRAG_0507.pdf.
81. Thomas S.D., Mackenzie M., Rogers D.W.O., Fallone B.G. A Monte Carlo derived TG-51 equivalent calibration for helical Tomotherapy. Med Phys 2005, 32(5):1346-1353.
82. Duane S., Nicholas D., Palmans H., et al. Dosimetry audit for tomotherapy using alanine/EPR. Med Phys 2006, 33(6):2093-2094.
83. Alfonso R., Andreo P., Capote R., et al. A new formalism for reference dosimetry of small and nonstandard fields. Med Phys 2008, 35(11):5179-5186.